Quality indicators of supportive care for patients with cancer undergoing treatment: a systematic review
Patients need to be supported in combining treatment with daily life. However, measurement of supportive care indicators related to treatment-related side effects is under-reported. This review aimed to identify a list of quality indicators for managing cancer treatment-induced toxicities for adult...
Saved in:
| Published in | BMC cancer Vol. 25; no. 1; pp. 103 - 8 |
|---|---|
| Main Authors | , , |
| Format | Journal Article |
| Language | English |
| Published |
England
BioMed Central Ltd
20.01.2025
BioMed Central BMC |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1471-2407 1471-2407 |
| DOI | 10.1186/s12885-025-13519-z |
Cover
Loading…
| Abstract | Patients need to be supported in combining treatment with daily life. However, measurement of supportive care indicators related to treatment-related side effects is under-reported. This review aimed to identify a list of quality indicators for managing cancer treatment-induced toxicities for adult patients with cancer.
A review was conducted on PubMed, the Cumulative Index to Nursing and Allied Health Literature, the Cochrane Database of Systematic Reviews, and Embase from September 26, 2013 to December 26, 2023. Published English articles that developed or analyzed quality indicators of managing cancer treatment-induced toxicities for adult patients with cancer were selected. The identified indicators were classified according to Donabedian's model for quality of care in healthcare.
Forty-two indicators (4 structural, 27 process, and 11 outcome indicators) in 18 articles were identified. Eight articles (44.4%) were from North America, four (22.2%) from Europe, two (11.1%) from Oceania, two (11.1%) from Asia, and one (5.6%) from Africa; 64.3% of the indicators were process indicators based on guidelines. The prevalence of patient symptoms determined using a patient-reported outcome measure was proposed as an outcome indicator. In seven studies (38.9%), these indicators were selected by multidisciplinary experts. None of the studies involved patients or family members in the indicator selection process.
The quality of supportive care should be improved by measuring these indicators, considering the patient's needs for supportive care at each hospital such that patients can continue their lives while undergoing treatment. |
|---|---|
| AbstractList | Background Patients need to be supported in combining treatment with daily life. However, measurement of supportive care indicators related to treatment-related side effects is under-reported. This review aimed to identify a list of quality indicators for managing cancer treatment-induced toxicities for adult patients with cancer. Methods A review was conducted on PubMed, the Cumulative Index to Nursing and Allied Health Literature, the Cochrane Database of Systematic Reviews, and Embase from September 26, 2013 to December 26, 2023. Published English articles that developed or analyzed quality indicators of managing cancer treatment-induced toxicities for adult patients with cancer were selected. The identified indicators were classified according to Donabedian's model for quality of care in healthcare. Results Forty-two indicators (4 structural, 27 process, and 11 outcome indicators) in 18 articles were identified. Eight articles (44.4%) were from North America, four (22.2%) from Europe, two (11.1%) from Oceania, two (11.1%) from Asia, and one (5.6%) from Africa; 64.3% of the indicators were process indicators based on guidelines. The prevalence of patient symptoms determined using a patient-reported outcome measure was proposed as an outcome indicator. In seven studies (38.9%), these indicators were selected by multidisciplinary experts. None of the studies involved patients or family members in the indicator selection process. Conclusion The quality of supportive care should be improved by measuring these indicators, considering the patient's needs for supportive care at each hospital such that patients can continue their lives while undergoing treatment. Keywords: Supportive care, Quality indicators, Review, Multidisciplinary A review was conducted on PubMed, the Cumulative Index to Nursing and Allied Health Literature, the Cochrane Database of Systematic Reviews, and Embase from September 26, 2013 to December 26, 2023. Published English articles that developed or analyzed quality indicators of managing cancer treatment-induced toxicities for adult patients with cancer were selected. The identified indicators were classified according to Donabedian's model for quality of care in healthcare. Forty-two indicators (4 structural, 27 process, and 11 outcome indicators) in 18 articles were identified. Eight articles (44.4%) were from North America, four (22.2%) from Europe, two (11.1%) from Oceania, two (11.1%) from Asia, and one (5.6%) from Africa; 64.3% of the indicators were process indicators based on guidelines. The prevalence of patient symptoms determined using a patient-reported outcome measure was proposed as an outcome indicator. In seven studies (38.9%), these indicators were selected by multidisciplinary experts. None of the studies involved patients or family members in the indicator selection process. The quality of supportive care should be improved by measuring these indicators, considering the patient's needs for supportive care at each hospital such that patients can continue their lives while undergoing treatment. Patients need to be supported in combining treatment with daily life. However, measurement of supportive care indicators related to treatment-related side effects is under-reported. This review aimed to identify a list of quality indicators for managing cancer treatment-induced toxicities for adult patients with cancer. A review was conducted on PubMed, the Cumulative Index to Nursing and Allied Health Literature, the Cochrane Database of Systematic Reviews, and Embase from September 26, 2013 to December 26, 2023. Published English articles that developed or analyzed quality indicators of managing cancer treatment-induced toxicities for adult patients with cancer were selected. The identified indicators were classified according to Donabedian's model for quality of care in healthcare. Forty-two indicators (4 structural, 27 process, and 11 outcome indicators) in 18 articles were identified. Eight articles (44.4%) were from North America, four (22.2%) from Europe, two (11.1%) from Oceania, two (11.1%) from Asia, and one (5.6%) from Africa; 64.3% of the indicators were process indicators based on guidelines. The prevalence of patient symptoms determined using a patient-reported outcome measure was proposed as an outcome indicator. In seven studies (38.9%), these indicators were selected by multidisciplinary experts. None of the studies involved patients or family members in the indicator selection process. The quality of supportive care should be improved by measuring these indicators, considering the patient's needs for supportive care at each hospital such that patients can continue their lives while undergoing treatment. BackgroundPatients need to be supported in combining treatment with daily life. However, measurement of supportive care indicators related to treatment-related side effects is under-reported. This review aimed to identify a list of quality indicators for managing cancer treatment-induced toxicities for adult patients with cancer.MethodsA review was conducted on PubMed, the Cumulative Index to Nursing and Allied Health Literature, the Cochrane Database of Systematic Reviews, and Embase from September 26, 2013 to December 26, 2023. Published English articles that developed or analyzed quality indicators of managing cancer treatment-induced toxicities for adult patients with cancer were selected. The identified indicators were classified according to Donabedian’s model for quality of care in healthcare.ResultsForty-two indicators (4 structural, 27 process, and 11 outcome indicators) in 18 articles were identified. Eight articles (44.4%) were from North America, four (22.2%) from Europe, two (11.1%) from Oceania, two (11.1%) from Asia, and one (5.6%) from Africa; 64.3% of the indicators were process indicators based on guidelines. The prevalence of patient symptoms determined using a patient-reported outcome measure was proposed as an outcome indicator. In seven studies (38.9%), these indicators were selected by multidisciplinary experts. None of the studies involved patients or family members in the indicator selection process.ConclusionThe quality of supportive care should be improved by measuring these indicators, considering the patient’s needs for supportive care at each hospital such that patients can continue their lives while undergoing treatment. Patients need to be supported in combining treatment with daily life. However, measurement of supportive care indicators related to treatment-related side effects is under-reported. This review aimed to identify a list of quality indicators for managing cancer treatment-induced toxicities for adult patients with cancer.BACKGROUNDPatients need to be supported in combining treatment with daily life. However, measurement of supportive care indicators related to treatment-related side effects is under-reported. This review aimed to identify a list of quality indicators for managing cancer treatment-induced toxicities for adult patients with cancer.A review was conducted on PubMed, the Cumulative Index to Nursing and Allied Health Literature, the Cochrane Database of Systematic Reviews, and Embase from September 26, 2013 to December 26, 2023. Published English articles that developed or analyzed quality indicators of managing cancer treatment-induced toxicities for adult patients with cancer were selected. The identified indicators were classified according to Donabedian's model for quality of care in healthcare.METHODSA review was conducted on PubMed, the Cumulative Index to Nursing and Allied Health Literature, the Cochrane Database of Systematic Reviews, and Embase from September 26, 2013 to December 26, 2023. Published English articles that developed or analyzed quality indicators of managing cancer treatment-induced toxicities for adult patients with cancer were selected. The identified indicators were classified according to Donabedian's model for quality of care in healthcare.Forty-two indicators (4 structural, 27 process, and 11 outcome indicators) in 18 articles were identified. Eight articles (44.4%) were from North America, four (22.2%) from Europe, two (11.1%) from Oceania, two (11.1%) from Asia, and one (5.6%) from Africa; 64.3% of the indicators were process indicators based on guidelines. The prevalence of patient symptoms determined using a patient-reported outcome measure was proposed as an outcome indicator. In seven studies (38.9%), these indicators were selected by multidisciplinary experts. None of the studies involved patients or family members in the indicator selection process.RESULTSForty-two indicators (4 structural, 27 process, and 11 outcome indicators) in 18 articles were identified. Eight articles (44.4%) were from North America, four (22.2%) from Europe, two (11.1%) from Oceania, two (11.1%) from Asia, and one (5.6%) from Africa; 64.3% of the indicators were process indicators based on guidelines. The prevalence of patient symptoms determined using a patient-reported outcome measure was proposed as an outcome indicator. In seven studies (38.9%), these indicators were selected by multidisciplinary experts. None of the studies involved patients or family members in the indicator selection process.The quality of supportive care should be improved by measuring these indicators, considering the patient's needs for supportive care at each hospital such that patients can continue their lives while undergoing treatment.CONCLUSIONThe quality of supportive care should be improved by measuring these indicators, considering the patient's needs for supportive care at each hospital such that patients can continue their lives while undergoing treatment. Abstract Background Patients need to be supported in combining treatment with daily life. However, measurement of supportive care indicators related to treatment-related side effects is under-reported. This review aimed to identify a list of quality indicators for managing cancer treatment-induced toxicities for adult patients with cancer. Methods A review was conducted on PubMed, the Cumulative Index to Nursing and Allied Health Literature, the Cochrane Database of Systematic Reviews, and Embase from September 26, 2013 to December 26, 2023. Published English articles that developed or analyzed quality indicators of managing cancer treatment-induced toxicities for adult patients with cancer were selected. The identified indicators were classified according to Donabedian’s model for quality of care in healthcare. Results Forty-two indicators (4 structural, 27 process, and 11 outcome indicators) in 18 articles were identified. Eight articles (44.4%) were from North America, four (22.2%) from Europe, two (11.1%) from Oceania, two (11.1%) from Asia, and one (5.6%) from Africa; 64.3% of the indicators were process indicators based on guidelines. The prevalence of patient symptoms determined using a patient-reported outcome measure was proposed as an outcome indicator. In seven studies (38.9%), these indicators were selected by multidisciplinary experts. None of the studies involved patients or family members in the indicator selection process. Conclusion The quality of supportive care should be improved by measuring these indicators, considering the patient’s needs for supportive care at each hospital such that patients can continue their lives while undergoing treatment. |
| ArticleNumber | 103 |
| Audience | Academic |
| Author | Okuyama, Ayako Kuwabara, Mai Zenda, Sadamoto |
| Author_xml | – sequence: 1 givenname: Ayako surname: Okuyama fullname: Okuyama, Ayako – sequence: 2 givenname: Mai surname: Kuwabara fullname: Kuwabara, Mai – sequence: 3 givenname: Sadamoto surname: Zenda fullname: Zenda, Sadamoto |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39833732$$D View this record in MEDLINE/PubMed |
| BookMark | eNptkt1v0zAUxS00xLbCP8ADsoSE4CHDjuPE4QVNEx-VJiG-ni3XuUk9pXFnOx3dX8_tOkaDUB4SXf_uSc7JOSVHgx-AkOecnXGuyreR50rJjOUy40LyOrt9RE54UfEsL1h1dPB8TE5jvGKMV4qpJ-RY1EqISuQnZPl1NL1LW-qGxlmTfIjUtzSO67UPyW2AWhOAtj7QtUkOhhTpjUtLHA8WAh2HBkLn3dDRFMCkFRLvqKFxGxOscMPSABsHN0_J49b0EZ7d32fk58cPPy4-Z5dfPs0vzi8zKxVLmRR5jbZK1Ta5NTVrGH6rXNRcmbqpawlGQqFaJiVYUZQtXwiQlcVjaYVaVGJG5nvdxpsrvQ5uZcJWe-P03cCHThs0ZnvQvJGlZaxqzU5KcCVbAWVhMMuSVbxBrfd7rfW4WEFj0Vsw_UR0ejK4pe78RnNeFYXCjGfk9b1C8NcjxKRXLlroezOAH6MWXFZSFrWUiL78B73yYxgwK6RKKTky1V-qM-jADa3HF9udqD5XeYE-FP7bGTn7D4VXAytnsUWtw_lk4c1kAZkEv1Jnxhj1_Pu3KfvqgF2C6dMy-n5Mzg9xCr44jO8htz_tQyDfAzb4GAO0Dwhneldxva-4xorru4rrW_EbzyHr4Q |
| Cites_doi | 10.1093/annonc/mdx757 10.1007/s00520-017-3823-4 10.1016/j.ejca.2022.10.017 10.1016/j.ygyno.2021.12.002 10.1200/JOP.2013.001237 10.1007/978-3-319-90990-5_1 10.1016/j.amjsurg.2008.06.027 10.1016/j.urolonc.2016.12.003 10.1016/j.jpainsymman.2008.07.008 10.1093/intqhc/mzv042 10.2147/PROM.S201737 10.1016/j.amjsurg.2006.05.012 10.1016/j.gie.2014.07.058 10.1111/ajco.13917 10.1200/JCO.2013.49.4302 10.1182/bloodadvances.2020002314 10.1002/cam4.6541 10.1111/j.1468-0009.2005.00397.x 10.1093/jjco/hyab008 10.3390/cancers15020337 10.1007/s11060-022-03971-3 10.1186/1471-2288-6-35 10.1001/jamaoto.2023.2177 10.1007/s00520-014-2508-5 10.1097/JTO.0000000000000108 10.3390/curroncol30070451 10.1002/lary.24593 10.1200/JOP.18.00390 10.1016/j.gie.2014.07.054 10.1200/JOP.19.00466 10.1016/j.jpainsymman.2012.09.013 10.1001/jamanetworkopen.2021.2474 10.1111/cas.12837 10.1093/ehjqcco/qcac070 10.1007/s10147-024-02535-x |
| ContentType | Journal Article |
| Copyright | 2025. The Author(s). COPYRIGHT 2025 BioMed Central Ltd. 2025. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2025 2025 |
| Copyright_xml | – notice: 2025. The Author(s). – notice: COPYRIGHT 2025 BioMed Central Ltd. – notice: 2025. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2025 2025 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM ISR 3V. 7TO 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.1186/s12885-025-13519-z |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Science In Context ProQuest Central (Corporate) Oncogenes and Growth Factors Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection PML(ProQuest Medical Library) ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database Oncogenes and Growth Factors Abstracts ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE Publicly Available Content Database MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1471-2407 |
| EndPage | 8 |
| ExternalDocumentID | oai_doaj_org_article_1d56c007fac3463185f3e64a3516071d PMC11744883 A824346898 39833732 10_1186_s12885_025_13519_z |
| Genre | Systematic Review Journal Article |
| GeographicLocations | Japan |
| GeographicLocations_xml | – name: Japan |
| GrantInformation_xml | – fundername: the Grants-In-Aid for Scientific Research in Japan grantid: KAKENHI23EA1035 |
| GroupedDBID | --- 0R~ 23N 2WC 53G 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL AAYXX ABDBF ABUWG ACGFO ACGFS ACIHN ACMJI ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR IHW INH INR ISR ITC KQ8 LGEZI LOTEE M1P M48 M~E NADUK NXXTH O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SBL SOJ SV3 TR2 TUS U2A UKHRP W2D WOQ WOW XSB CGR CUY CVF ECM EIF NPM PJZUB PPXIY PMFND 3V. 7TO 7XB 8FK AZQEC DWQXO H94 K9. PKEHL PQEST PQUKI PRINS 7X8 5PM PUEGO |
| ID | FETCH-LOGICAL-c580t-532912868fd2ca90d03985b918a9d995ea5e48f055ec346f1b3e57c18a5c38b73 |
| IEDL.DBID | M48 |
| ISSN | 1471-2407 |
| IngestDate | Wed Aug 27 01:29:20 EDT 2025 Thu Aug 21 18:40:09 EDT 2025 Fri Jul 11 08:44:24 EDT 2025 Fri Jul 25 21:33:24 EDT 2025 Tue Jun 17 22:00:02 EDT 2025 Tue Jun 10 20:54:23 EDT 2025 Fri Jun 27 05:15:09 EDT 2025 Thu May 22 21:23:32 EDT 2025 Mon Jul 21 05:33:57 EDT 2025 Tue Jul 01 04:29:53 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Quality indicators Supportive care Review Multidisciplinary |
| Language | English |
| License | 2025. The Author(s). Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c580t-532912868fd2ca90d03985b918a9d995ea5e48f055ec346f1b3e57c18a5c38b73 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12885-025-13519-z |
| PMID | 39833732 |
| PQID | 3165515537 |
| PQPubID | 44074 |
| PageCount | 8 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_1d56c007fac3463185f3e64a3516071d pubmedcentral_primary_oai_pubmedcentral_nih_gov_11744883 proquest_miscellaneous_3157554955 proquest_journals_3165515537 gale_infotracmisc_A824346898 gale_infotracacademiconefile_A824346898 gale_incontextgauss_ISR_A824346898 gale_healthsolutions_A824346898 pubmed_primary_39833732 crossref_primary_10_1186_s12885_025_13519_z |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2025-01-20 |
| PublicationDateYYYYMMDD | 2025-01-20 |
| PublicationDate_xml | – month: 01 year: 2025 text: 2025-01-20 day: 20 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London |
| PublicationTitle | BMC cancer |
| PublicationTitleAlternate | BMC Cancer |
| PublicationYear | 2025 |
| Publisher | BioMed Central Ltd BioMed Central BMC |
| Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
| References | AM Ma (13519_CR3) 2008; 196 H Iihara (13519_CR9) 2024; 29 GB Rocque (13519_CR29) 2019; 15 ML De Roo (13519_CR12) 2013; 46 SM Dy (13519_CR20) 2014; 10 J Landercasper (13519_CR4) 2006; 192 M Iwamoto (13519_CR26) 2016; 107 S Sundar (13519_CR6) 2023; 15 LA Gharzai (13519_CR1) 2023; 149 13519_CR22 S Zenda (13519_CR15) 2021; 51 KE Williams (13519_CR28) 2018; 26 JM Boyle (13519_CR35) 2023; 178 SR Khare (13519_CR27) 2017; 35 S Wani (13519_CR23) 2015; 81 JB Shelton (13519_CR19) 2014; 20 CG Gourin (13519_CR21) 2014; 124 13519_CR18 13519_CR16 13519_CR37 13519_CR8 NL Keating (13519_CR7) 2021; 4 HR Pasman (13519_CR13) 2009; 38 13519_CR32 M van Ryn (13519_CR10) 2014; 32 M Dixon-Woods (13519_CR17) 2006; 6 K Stojkov (13519_CR31) 2020; 4 C Donnelly (13519_CR36) 2024; 20 IB Rego (13519_CR5) 2023; 30 K Jordan (13519_CR11) 2018; 29 NM Brown (13519_CR14) 2015; 23 DK Rex (13519_CR25) 2015; 81 GA Lee (13519_CR33) 2022; 9 H Bao (13519_CR24) 2015; 27 V Guarneri (13519_CR30) 2020; 16 CM Bastemeijer (13519_CR38) 2019; 10 BH Chaballout (13519_CR2) 2023; 12 RJ DeBoer (13519_CR34) 2022; 164 |
| References_xml | – volume: 29 start-page: 36 year: 2018 ident: 13519_CR11 publication-title: Ann Oncol doi: 10.1093/annonc/mdx757 – volume: 26 start-page: 129 year: 2018 ident: 13519_CR28 publication-title: Support Care Cancer doi: 10.1007/s00520-017-3823-4 – volume: 178 start-page: 191 year: 2023 ident: 13519_CR35 publication-title: Eur J Cancer doi: 10.1016/j.ejca.2022.10.017 – volume: 164 start-page: 370 year: 2022 ident: 13519_CR34 publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2021.12.002 – volume: 10 start-page: e223 year: 2014 ident: 13519_CR20 publication-title: J Oncol Pract doi: 10.1200/JOP.2013.001237 – ident: 13519_CR37 doi: 10.1007/978-3-319-90990-5_1 – volume: 196 start-page: 500 year: 2008 ident: 13519_CR3 publication-title: Am J Surg doi: 10.1016/j.amjsurg.2008.06.027 – volume: 35 start-page: 328 year: 2017 ident: 13519_CR27 publication-title: Urol Oncol doi: 10.1016/j.urolonc.2016.12.003 – volume: 38 start-page: 145 year: 2009 ident: 13519_CR13 publication-title: J Pain Symptom Manage doi: 10.1016/j.jpainsymman.2008.07.008 – ident: 13519_CR16 – volume: 27 start-page: 291 year: 2015 ident: 13519_CR24 publication-title: Int J Qual Health Care doi: 10.1093/intqhc/mzv042 – volume: 10 start-page: 157 year: 2019 ident: 13519_CR38 publication-title: Patient Relat Outcome Meas doi: 10.2147/PROM.S201737 – volume: 192 start-page: 525 year: 2006 ident: 13519_CR4 publication-title: Am J Surg doi: 10.1016/j.amjsurg.2006.05.012 – volume: 81 start-page: 31 year: 2015 ident: 13519_CR25 publication-title: Gastrointest Endosc doi: 10.1016/j.gie.2014.07.058 – ident: 13519_CR8 – volume: 20 start-page: 259 year: 2024 ident: 13519_CR36 publication-title: Asia Pac J Clin Oncol doi: 10.1111/ajco.13917 – volume: 32 start-page: 809 year: 2014 ident: 13519_CR10 publication-title: J Clin Oncol doi: 10.1200/JCO.2013.49.4302 – volume: 4 start-page: 4029 year: 2020 ident: 13519_CR31 publication-title: Blood Adv doi: 10.1182/bloodadvances.2020002314 – volume: 12 start-page: 19978 year: 2023 ident: 13519_CR2 publication-title: Cancer Med doi: 10.1002/cam4.6541 – ident: 13519_CR18 doi: 10.1111/j.1468-0009.2005.00397.x – volume: 51 start-page: 538 year: 2021 ident: 13519_CR15 publication-title: Jpn J Clin Oncol doi: 10.1093/jjco/hyab008 – volume: 15 start-page: 337 year: 2023 ident: 13519_CR6 publication-title: Cancers (Basel) doi: 10.3390/cancers15020337 – ident: 13519_CR32 doi: 10.1007/s11060-022-03971-3 – volume: 6 start-page: 35 year: 2006 ident: 13519_CR17 publication-title: BMC Med Res Methodol doi: 10.1186/1471-2288-6-35 – volume: 149 start-page: 884 year: 2023 ident: 13519_CR1 publication-title: JAMA Otolaryngol Head Neck Surg doi: 10.1001/jamaoto.2023.2177 – volume: 23 start-page: 1533 year: 2015 ident: 13519_CR14 publication-title: Support Care Cancer doi: 10.1007/s00520-014-2508-5 – volume: 20 start-page: 1041 year: 2014 ident: 13519_CR19 publication-title: Am J Manag Care – ident: 13519_CR22 doi: 10.1097/JTO.0000000000000108 – volume: 30 start-page: 6041 year: 2023 ident: 13519_CR5 publication-title: Curr Oncol doi: 10.3390/curroncol30070451 – volume: 124 start-page: 2049 year: 2014 ident: 13519_CR21 publication-title: Laryngoscope doi: 10.1002/lary.24593 – volume: 15 start-page: e271 year: 2019 ident: 13519_CR29 publication-title: J Oncol Pract doi: 10.1200/JOP.18.00390 – volume: 81 start-page: 67 year: 2015 ident: 13519_CR23 publication-title: Gastrointest Endosc doi: 10.1016/j.gie.2014.07.054 – volume: 16 start-page: e211 year: 2020 ident: 13519_CR30 publication-title: JCO Oncol Pract doi: 10.1200/JOP.19.00466 – volume: 46 start-page: 556 year: 2013 ident: 13519_CR12 publication-title: J Pain Symptom Manage doi: 10.1016/j.jpainsymman.2012.09.013 – volume: 4 start-page: e212474 year: 2021 ident: 13519_CR7 publication-title: JAMA Netw Open doi: 10.1001/jamanetworkopen.2021.2474 – volume: 107 start-page: 68 year: 2016 ident: 13519_CR26 publication-title: Cancer Sci doi: 10.1111/cas.12837 – volume: 9 start-page: 1 year: 2022 ident: 13519_CR33 publication-title: Eur Heart J Qual Care Clin Outcomes doi: 10.1093/ehjqcco/qcac070 – volume: 29 start-page: 873 issue: 7 year: 2024 ident: 13519_CR9 publication-title: Int J Clin Oncol doi: 10.1007/s10147-024-02535-x |
| SSID | ssj0017808 |
| Score | 2.4327042 |
| SecondaryResourceType | review_article |
| Snippet | Patients need to be supported in combining treatment with daily life. However, measurement of supportive care indicators related to treatment-related side... Background Patients need to be supported in combining treatment with daily life. However, measurement of supportive care indicators related to... A review was conducted on PubMed, the Cumulative Index to Nursing and Allied Health Literature, the Cochrane Database of Systematic Reviews, and Embase from... BackgroundPatients need to be supported in combining treatment with daily life. However, measurement of supportive care indicators related to treatment-related... Abstract Background Patients need to be supported in combining treatment with daily life. However, measurement of supportive care indicators related to... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database |
| StartPage | 103 |
| SubjectTerms | Cancer Cancer therapies Care and treatment Chemotherapy Clinical practice guidelines Hospitals Humans Medical care Medical personnel Medical Subject Headings-MeSH Multidisciplinary Neoplasms - therapy Outpatients Palliative care Patient Reported Outcome Measures Patients Prevention Professional ethics Quality indicators Quality Indicators, Health Care Quality management Quality of Life Review Side effects Supportive care Systematic Review |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gLopRHaKEGIXFAUZ34EYdbQVQFCQ5Apd4sx4-WS1Jtdg_01zMTe8NGHLhwzUyiZGY8j3jmMyGvla6bWDlWMh5UKaRXJcRxW1aiibprK6Rht8VXdX4hPl_Ky52jvrAnLMEDJ8GdVF4qB4EsWseFwlnfCE8VlssJGs2j94WYty2m8v5Bo5nejshodTKCF9Y4iSzL6US68nYRhia0_r998k5QWjZM7kSgswfkfk4d6Wl65X1yJ_QPyd0veXP8gFwnPIxfFLehHRbTIx0iHTc3mGODV6PY5kUhS6UZTXWk-BsWLoPmVxTHyVZXA8QyOrefv6OW_gF7pmnQ5RG5OPv448N5mQ9SKJ3UbF1KXrcgAaWjr51tmWe81RI0oW3r21YGK4PQkUkZUMix6niQjQOydFx3DX9M9vqhD08JFUp4z7xkna-Ft66THB7hQuXbOkC1WZC3W7mam4SXYaY6QyuTtGBAC2bSgrktyHsU_cyJWNfTBbAAky3A_MsCCnKMijNpcHReseZU1wJu0K0uyKuJA_EuemyoubKbcTSfvn9bML3JTHEAJTub5xPguxEia8F5tOCEBemW5K0FmewQRsMrJfE0Hd4U5OVMxjuxya0PwwZ5IHeGel2CFJ8kg5slAwrjvOF1QfTCFBeiW1L6n9cTXHgFRSe4af7sfwj7kNyrcRmxCvzrEdlbrzbhOaRl6-7FtAJ_Az2WM0A priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagSIhLxZtAKQYhcUBR7fgRhwsqFVVBggNQaW-WYztbLsl2s3ugv56ZxJs2QuIaj6NkXp6xZz4T8labomy4ZzkTUedSBZ3DOu5yLsvG1BXHMay2-K7PzuXXhVqkDbc-lVXufOLgqEPncY_8SHCt8DoSUX5cXeZ4axSerqYrNG6TOwhdhiVd5WJKuHhpmNk1yhh91IMvNtiPrPLhXrr8arYYDZj9_3rmG0vTvGzyxjp0ep_spwCSHo8Sf0BuxfYhufstHZE_IhcjKsYfiofRHlPqnnYN7bcrjLTBt1Es9qIQq9KEqdpT3IyFxyD_NcWmsvWygxWNTkXoH6ij15DPdGx3eUzOTz__OjnL03UKuVeGbXIligo4oE0TCu8qFpiojAJ5GFeFqlLRqShNw5SKXkjd8FpEVXoYVl6YuhRPyF7btfEZoVLLEFhQrA6FDM7XSsArfOShKiLknBl5v-OrXY2oGXbINoy2oxQsSMEOUrBXGfmErJ8oEfF6eNCtlzYZkOVBaQ8BTePw47DnuwHtkg5egRB5ISOvUHB2bB-d7NYem0LCBFOZjLwZKBD1osWymqXb9r398vPHjOhdImo6ELJ3qUsB_huBsmaUBzNKMEs_H95pkE1uobfXSpyR19MwzsRStzZ2W6SBCBqydgVcfDoq3MQZEJgQpSgyYmaqOGPdfKT9fTGAhnNIPcFZi-f__64X5F6BBsI4-M8DsrdZb-NLCLs29eFgW38BKQAr4Q priority: 102 providerName: ProQuest |
| Title | Quality indicators of supportive care for patients with cancer undergoing treatment: a systematic review |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/39833732 https://www.proquest.com/docview/3165515537 https://www.proquest.com/docview/3157554955 https://pubmed.ncbi.nlm.nih.gov/PMC11744883 https://doaj.org/article/1d56c007fac3463185f3e64a3516071d |
| Volume | 25 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1da9RAcOgHiC_it9F6riL4ILFJ9iMbQaQnLVVokdODw5cl2d1cBUnq5Q5sf70zSe7aYJ98yUN2NiTzPdn5AHitdJKWsY3CiHsVCulUiHY8D2ORlrrIYlqjbItTdTwVX2ZytgXrcUc9ApsbQzuaJzVd_Hr35_fFRxT4D63Aa7XfoI7VVGcsw3beXHi5DbtomVIS1BNxdaqQ6kivC2du3DcwTm0P_3819TVTNUyjvGaXju7Cnd6hZAcdB9yDLV_dh1sn_ZH5AzjrumRcMDqcthRiN6wuWbM6p49GXcco-Yuh78r6HqsNo5-zeBv5YcGoyGwxr9HCsU1S-nuWs6sW0Kwrf3kI06PD75-Ow368Qmiljpah5EmGGFC6dInNs8hFPNMS6aPzzGWZ9Ln0QpeRlN5yocq44F6mFpel5bpI-SPYqerKPwEmlHAucjIqXCJcbgvJ8RHWxy5LPMagAbxd49Wcd100TBt9aGU6KhikgmmpYC4DGBPqN5DUAbu9US_mphcoEzupLDo4ZU4vRzXgJXKbyPER1DLPBfCCCGe6ctKNHJsDnQjcoDMdwKsWgrpgVJRmM89XTWM-f5sMgN70QGWNRLZ5X7WA302NswaQewNIFFM7XF5zkFlzueGxkjRjh6cBvNws005Kfat8vSIY9KgxipeIxccdw20wgwTjPOVJAHrAigPUDVeqn2dtE_EYQ1FU3vzp_299BrcTEp4oRl27BzvLxco_RxdtWYxgO52lI9gdH55-nYzaHx2jVhbxOhn_-Au4Nz-z |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3LbtQw0CpbCbgg3gQKNQjEAUVN4kccJIRaaLVL2xUqrdSbm9jOlkuybHaF2o_iG5nJq42QuPWamXi9M-N5xPMg5K1UUZyHJvAD5qTPhZU-2PHUD3mcqywJEYbZFlM5PuHfTsXpGvnT1cJgWmWnE2tFbUuD38i3WCgFjiNh8ef5Lx-nRuHtajdCoxGLfXfxG0K26tPkK_D3XRTt7R5_GfvtVAHfCBUsfcGiBJSyVLmNTJoENmCJErAtlSY2SYRLheMqD4RwhnGZhxlzIjYAFoapLGaw7i2yzhmEMiOyvrM7_X7U31vEKlBdaY6SWxX8kMIKaOHXk_D8y4H5q6cE_GsLrhnDYaLmNcu3d5_ca11Wut3I2AOy5oqH5PZheyn_iJw3fTguKF5_GwziK1rmtFrN0bcHbUoxvYyCd0zbLq4Vxc-_8BgkbkGxjG0xK8GG0j7t_SNN6VWTadoU2DwmJzdC6idkVJSFe0Yol9zawIogsxG3qckEgyWMC20SOYhyPfKho6ueN306dB3fKKkbLmjggq65oC89soOk7zGxx3b9oFzMdHtkdWiFNOBC5SluDqvMc5BnnsIS2JTPemQTGaebgtVeU-htFXF4QSXKI29qDOyzUWAizyxdVZWe_DgaIL1vkfISmGzSti4C_je25hpgbgwwQRGYIbiTIN0qokpfHRuPvO7B-CYm1xWuXCEO-OwCImWg4tNG4HrKAMMYi1nkETUQxQHphpDi53ndpjyEYBfMA3v-_31tkjvj48MDfTCZ7r8gdyM8LEEI2nuDjJaLlXsJTt8ye9WeNErObvpw_wXsfWkC |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Quality+indicators+of+supportive+care+for+patients+with+cancer+undergoing+treatment%3A+a+systematic+review&rft.jtitle=BMC+cancer&rft.au=Okuyama%2C+Ayako&rft.au=Kuwabara%2C+Mai&rft.au=Zenda%2C+Sadamoto&rft.date=2025-01-20&rft.pub=BioMed+Central&rft.eissn=1471-2407&rft.volume=25&rft_id=info:doi/10.1186%2Fs12885-025-13519-z&rft.externalDocID=PMC11744883 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2407&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2407&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2407&client=summon |